DCB-3503 produced a marked NF-κB-inhibition and affected cancer cell survival by blocking the translation phase of protein synthesis through a down-regulation of pro-oncogenic and pro-survival proteins, such as cyclin D1 [45]. The gene discussed is CCND1; the disease is cancer.